Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 211

1.

Experiences and supportive care needs of UK patients with pancreatic cancer: a cross-sectional questionnaire survey.

Watson EK, Brett J, Hay H, Witwicki C, Perris A, Poots AJ, Sizmur S, Soonawalla Z, Tallett A.

BMJ Open. 2019 Nov 4;9(11):e032681. doi: 10.1136/bmjopen-2019-032681.

2.

Adjustment strategies amongst black African and black Caribbean men following treatment for prostate cancer: Findings from the Life After Prostate Cancer Diagnosis (LAPCD) study.

Wagland R, Nayoan J, Matheson L, Rivas C, Brett J, Collaco N, Alexis O, Gavin A, Glaser AW, Watson E.

Eur J Cancer Care (Engl). 2019 Oct 23:e13183. doi: 10.1111/ecc.13183. [Epub ahead of print]

PMID:
31642565
3.

Extra-medical use of antipsychotics: What can be learnt from experiences with other prescription medicines?

Gisev N, Brett J, Peacock A.

Addiction. 2019 Sep 14. doi: 10.1111/add.14823. [Epub ahead of print] No abstract available.

PMID:
31522455
4.

What if something goes wrong? A grounded theory study of parents' decision-making processes around mode of breech birth at term gestation.

Thompson E, Brett J, Burns E.

Midwifery. 2019 Nov;78:114-122. doi: 10.1016/j.midw.2019.08.006. Epub 2019 Aug 9.

PMID:
31421541
5.

Genomics for Molecular Epidemiology and Detecting Transmission of Carbapenemase-Producing Enterobacterales in Victoria, Australia, 2012 to 2016.

Sherry NL, Lane CR, Kwong JC, Schultz M, Sait M, Stevens K, Ballard S, Gonçalves da Silva A, Seemann T, Gorrie CL, Stinear TP, Williamson DA, Brett J, van Diemen A, Easton M, Howden BP.

J Clin Microbiol. 2019 Aug 26;57(9). pii: e00573-19. doi: 10.1128/JCM.00573-19. Print 2019 Sep.

6.

The prevalence of cardiovascular disease and antidiabetes treatment characteristics among a large type 2 diabetes population in the United States.

Weng W, Tian Y, Kong SX, Ganguly R, Hersloev M, Brett J, Hobbs T.

Endocrinol Diabetes Metab. 2019 May 22;2(3):e00076. doi: 10.1002/edm2.76. eCollection 2019 Jul.

7.

High-dose insulin euglycemic therapy to treat cardiomyopathy associated with massive venlafaxine overdose.

Stefani M, Roberts DM, Brett J.

Clin Toxicol (Phila). 2019 Jul 10:1-2. doi: 10.1080/15563650.2019.1638930. [Epub ahead of print] No abstract available.

PMID:
31290339
8.

The relative lethal toxicity of pharmaceutical and illicit substances: A 16-year study of the Greater Newcastle Hunter Area, Australia.

Brett J, Wylie CE, Raubenheimer J, Isbister GK, Buckley NA.

Br J Clin Pharmacol. 2019 Sep;85(9):2098-2107. doi: 10.1111/bcp.14019. Epub 2019 Jul 17.

PMID:
31173392
9.

The psychological impact of being on a monitoring pathway for localised prostate cancer: A UK-wide mixed methods study.

Matheson L, Wilding S, Wagland R, Nayoan J, Rivas C, Downing A, Wright P, Brett J, Kearney T, Cross W, Glaser A, Gavin A, Watson E.

Psychooncology. 2019 Jul;28(7):1567-1575. doi: 10.1002/pon.5133. Epub 2019 Jun 10.

PMID:
31132801
10.

A case of significant hypotension following a human ingestion of veterinary pimobendan.

Brett J, Wylie C, Brown J.

Clin Toxicol (Phila). 2019 May 20:1-2. doi: 10.1080/15563650.2019.1613550. [Epub ahead of print] No abstract available.

PMID:
31106604
11.

Availability and quality assessment of online nutrition information materials for pelvic cancer patients in the UK.

Saltaouras G, Lightowler H, Coe S, Brett J, Watson EK.

Eur J Cancer Care (Engl). 2019 Jul;28(4):e13039. doi: 10.1111/ecc.13039. Epub 2019 Apr 16.

PMID:
30990233
12.

Measuring 21 low-value hospital procedures: claims analysis of Australian private health insurance data (2010-2014).

Chalmers K, Pearson SA, Badgery-Parker T, Brett J, Scott IA, Elshaug AG.

BMJ Open. 2019 Mar 5;9(3):e024142. doi: 10.1136/bmjopen-2018-024142.

13.

Choosing wisely? Quantifying the extent of three low value psychotropic prescribing practices in Australia.

Brett J, Zoega H, Buckley NA, Daniels BJ, Elshaug AG, Pearson SA.

BMC Health Serv Res. 2018 Dec 29;18(1):1009. doi: 10.1186/s12913-018-3811-5.

14.

Development of an e-health app to support women prescribed adjuvant endocrine therapy after treatment for breast cancer.

Brett J, Boulton M, Watson E.

Patient Prefer Adherence. 2018 Dec 11;12:2639-2647. doi: 10.2147/PPA.S187692. eCollection 2018.

15.

'Very difficult for an ordinary guy': Factors influencing the quality of treatment decision-making amongst men diagnosed with localised and locally advanced prostate cancer: Findings from a UK-wide mixed methods study.

Wagland R, Nayoan J, Matheson L, Rivas C, Brett J, Downing A, Wilding S, Butcher H, Gavin A, Glaser AW, Watson E.

Patient Educ Couns. 2019 Apr;102(4):797-803. doi: 10.1016/j.pec.2018.12.004. Epub 2018 Dec 3.

PMID:
30527732
16.

Carbapenemase-producing Enterobacteriaceae in Australian hospitals: outcome of point-prevalence screening in high-risk wards.

Brett JA, Johnson SA, Cameron DRM, Lane CR, Easton M, van Diemen A, Sutton B, Bull AL, Richards MJ, Worth LJ.

J Hosp Infect. 2019 Feb;101(2):163-166. doi: 10.1016/j.jhin.2018.08.008. Epub 2018 Aug 10.

PMID:
30102948
17.

Low-value care in Australian public hospitals: prevalence and trends over time.

Badgery-Parker T, Pearson SA, Chalmers K, Brett J, Scott IA, Dunn S, Onley N, Elshaug AG.

BMJ Qual Saf. 2019 Mar;28(3):205-214. doi: 10.1136/bmjqs-2018-008338. Epub 2018 Aug 6.

18.

Retinal Degeneration in Choroideremia follows an Exponential Decay Function.

Aylward JW, Xue K, Patrício MI, Jolly JK, Wood JC, Brett J, Jasani KM, MacLaren RE.

Ophthalmology. 2018 Jul;125(7):1122-1124. doi: 10.1016/j.ophtha.2018.02.004. Epub 2018 Mar 23. No abstract available.

19.

Developing indicators for measuring low-value care: mapping Choosing Wisely recommendations to hospital data.

Chalmers K, Badgery-Parker T, Pearson SA, Brett J, Scott IA, Elshaug AG.

BMC Res Notes. 2018 Mar 5;11(1):163. doi: 10.1186/s13104-018-3270-4.

20.

Adjuvant endocrine therapy after breast cancer: a qualitative study of factors associated with adherence.

Brett J, Boulton M, Fenlon D, Hulbert-Williams NJ, Walter FM, Donnelly P, Lavery BA, Morgan A, Morris C, Watson EK.

Patient Prefer Adherence. 2018 Feb 16;12:291-300. doi: 10.2147/PPA.S145784. eCollection 2018.

21.

The impact of permissive and restrictive pharmaceutical policies on quetiapine dispensing: Evaluating a policy pendulum using interrupted time series analysis.

Brett J, Schaffer A, Dobbins T, Buckley NA, Pearson SA.

Pharmacoepidemiol Drug Saf. 2018 Apr;27(4):439-446. doi: 10.1002/pds.4408. Epub 2018 Feb 28.

PMID:
29493050
22.

Benzodiazepine Use in Older Adults in the United States, Ontario, and Australia from 2010 to 2016.

Brett J, Maust DT, Bouck Z, Ignacio RV, Mecredy G, Kerr EA, Bhatia S, Elshaug AG, Pearson SA.

J Am Geriatr Soc. 2018 Jul;66(6):1180-1185. doi: 10.1111/jgs.15292. Epub 2018 Feb 12.

23.

Psychometric properties of the Beliefs about Medicine Questionnaire-adjuvant endocrine therapy (BMQ-AET) for women taking AETs following early-stage breast cancer.

Brett J, Hulbert-Williams NJ, Fenlon D, Boulton M, Walter FM, Donnelly P, Lavery B, Morgan A, Morris C, Horne R, Watson E.

Health Psychol Open. 2017 Nov 17;4(2):2055102917740469. doi: 10.1177/2055102917740469. eCollection 2017 Jul-Dec.

24.

Trends in opioid utilisation in Australia, 2006-2015: Insights from multiple metrics.

Karanges EA, Buckley NA, Brett J, Blanch B, Litchfield M, Degenhardt L, Pearson SA.

Pharmacoepidemiol Drug Saf. 2018 May;27(5):504-512. doi: 10.1002/pds.4369. Epub 2017 Dec 27.

PMID:
29280224
25.

Central and peripheral line-associated bloodstream infections in Australian neonatal and paediatric intensive care units: findings from a comprehensive Victorian surveillance network, 2008-2016.

Worth LJ, Daley AJ, Spelman T, Bull AL, Brett JA, Richards MJ.

J Hosp Infect. 2018 May;99(1):55-61. doi: 10.1016/j.jhin.2017.11.021. Epub 2017 Dec 6.

PMID:
29222036
26.

Transcriptional Profiling of Quiescent Muscle Stem Cells In Vivo.

van Velthoven CTJ, de Morree A, Egner IM, Brett JO, Rando TA.

Cell Rep. 2017 Nov 14;21(7):1994-2004. doi: 10.1016/j.celrep.2017.10.037.

27.

GRIPP2 reporting checklists: tools to improve reporting of patient and public involvement in research.

Staniszewska S, Brett J, Simera I, Seers K, Mockford C, Goodlad S, Altman DG, Moher D, Barber R, Denegri S, Entwistle A, Littlejohns P, Morris C, Suleman R, Thomas V, Tysall C.

Res Involv Engagem. 2017 Aug 2;3:13. doi: 10.1186/s40900-017-0062-2. eCollection 2017.

28.

Reaching consensus on reporting patient and public involvement (PPI) in research: methods and lessons learned from the development of reporting guidelines.

Brett J, Staniszewska S, Simera I, Seers K, Mockford C, Goodlad S, Altman D, Moher D, Barber R, Denegri S, Entwistle AR, Littlejohns P, Morris C, Suleman R, Thomas V, Tysall C.

BMJ Open. 2017 Oct 22;7(10):e016948. doi: 10.1136/bmjopen-2017-016948.

29.

GRIPP2 reporting checklists: tools to improve reporting of patient and public involvement in research.

Staniszewska S, Brett J, Simera I, Seers K, Mockford C, Goodlad S, Altman DG, Moher D, Barber R, Denegri S, Entwistle A, Littlejohns P, Morris C, Suleman R, Thomas V, Tysall C.

BMJ. 2017 Aug 2;358:j3453. doi: 10.1136/bmj.j3453.

30.

Psychotropic medication use in Australia, 2007 to 2015: Changes in annual incidence, prevalence and treatment exposure.

Brett J, Karanges EA, Daniels B, Buckley NA, Schneider C, Nassir A, Zoega H, McLachlan AJ, Pearson SA.

Aust N Z J Psychiatry. 2017 Oct;51(10):990-999. doi: 10.1177/0004867417721018. Epub 2017 Jul 31.

PMID:
28758432
31.

Psychotropic polypharmacy in Australia, 2006 to 2015: a descriptive cohort study.

Brett J, Daniels B, Karanges EA, Buckley NA, Schneider C, Nassir A, McLachlan AJ, Pearson SA.

Br J Clin Pharmacol. 2017 Nov;83(11):2581-2588. doi: 10.1111/bcp.13369. Epub 2017 Aug 16.

32.

Epidemiology of infections and antimicrobial use in Australian haemodialysis outpatients: findings from a Victorian surveillance network, 2008-2015.

Worth LJ, Spelman T, Holt SG, Brett JA, Bull AL, Richards MJ.

J Hosp Infect. 2017 Sep;97(1):93-98. doi: 10.1016/j.jhin.2017.05.018. Epub 2017 May 30.

PMID:
28576453
33.

A methodological protocol for selecting and quantifying low-value prescribing practices in routinely collected data: an Australian case study.

Brett J, Elshaug AG, Bhatia RS, Chalmers K, Badgery-Parker T, Pearson SA.

Implement Sci. 2017 May 3;12(1):58. doi: 10.1186/s13012-017-0585-9.

34.

Neuropsychiatric safety with liraglutide 3.0 mg for weight management: Results from randomized controlled phase 2 and 3a trials.

O'Neil PM, Aroda VR, Astrup A, Kushner R, Lau DCW, Wadden TA, Brett J, Cancino AP, Wilding JPH; Satiety and Clinical Adiposity - Liraglutide Evidence in individuals with and without diabetes (SCALE) study groups.

Diabetes Obes Metab. 2017 Nov;19(11):1529-1536. doi: 10.1111/dom.12963. Epub 2017 Jul 21.

35.

Maintenance of weight loss or stability in subjects with obesity: a retrospective longitudinal analysis of a real-world population.

DerSarkissian M, Bhak RH, Huang J, Buchs S, Vekeman F, Smolarz BG, Brett J, Ganguly R, Duh MS.

Curr Med Res Opin. 2017 Jun;33(6):1105-1110. doi: 10.1080/03007995.2017.1307173. Epub 2017 Apr 3.

PMID:
28294635
36.

Factors associated with intentional and unintentional non-adherence to adjuvant endocrine therapy following breast cancer.

Brett J, Fenlon D, Boulton M, Hulbert-Williams NJ, Walter FM, Donnelly P, Lavery B, Morgan A, Morris C, Watson E.

Eur J Cancer Care (Engl). 2018 Jan;27(1). doi: 10.1111/ecc.12601. Epub 2016 Nov 30.

PMID:
27901302
37.

Patient-reported outcome measures in older people with hip fracture: a systematic review of quality and acceptability.

Haywood KL, Brett J, Tutton E, Staniszewska S.

Qual Life Res. 2017 Apr;26(4):799-812. doi: 10.1007/s11136-016-1424-1. Epub 2016 Oct 20. Review.

PMID:
27766515
38.

Early diagnosis of dengue disease severity in a resource-limited Asian country.

Cavailler P, Tarantola A, Leo YS, Lover AA, Rachline A, Duch M, Huy R, Quake AL, Kdan Y, Duong V, Brett JL, Buchy P.

BMC Infect Dis. 2016 Sep 26;16(1):512.

39.

The Center for Human Development in Guatemala: An Innovative Model for Global Population Health.

Asturias EJ, Heinrichs G, Domek G, Brett J, Shick E, Cunningham M, Bull S, Celada M, Newman LS, Tenney L, Krisher L, Luna-Asturias C, McConnell K, Berman S.

Adv Pediatr. 2016 Aug;63(1):357-87. doi: 10.1016/j.yapd.2016.04.001. Epub 2016 Jun 3. No abstract available.

PMID:
27426907
40.

Goats display audience-dependent human-directed gazing behaviour in a problem-solving task.

Nawroth C, Brett JM, McElligott AG.

Biol Lett. 2016 Jul;12(7). pii: 20160283. doi: 10.1098/rsbl.2016.0283.

41.

An artificial niche preserves the quiescence of muscle stem cells and enhances their therapeutic efficacy.

Quarta M, Brett JO, DiMarco R, De Morree A, Boutet SC, Chacon R, Gibbons MC, Garcia VA, Su J, Shrager JB, Heilshorn S, Rando TA.

Nat Biotechnol. 2016 Jul;34(7):752-9. doi: 10.1038/nbt.3576. Epub 2016 May 30.

42.

Improvements in health-related quality of life with liraglutide 3.0 mg compared with placebo in weight management.

Kolotkin RL, Fujioka K, Wolden ML, Brett JH, Bjorner JB.

Clin Obes. 2016 Aug;6(4):233-42. doi: 10.1111/cob.12146. Epub 2016 May 19.

43.

Epidemiology of Clostridium difficile infections in Australia: enhanced surveillance to evaluate time trends and severity of illness in Victoria, 2010-2014.

Worth LJ, Spelman T, Bull AL, Brett JA, Richards MJ.

J Hosp Infect. 2016 Jul;93(3):280-5. doi: 10.1016/j.jhin.2016.03.014. Epub 2016 Mar 31.

PMID:
27107622
44.

The science of culture and negotiation.

Gunia BC, Brett JM, Gelfand MJ.

Curr Opin Psychol. 2016 Apr;8:78-83. doi: 10.1016/j.copsyc.2015.10.008. Epub 2015 Nov 10. Review.

PMID:
29506808
45.

ADHD medication overdose and misuse: the NSW Poisons Information Centre experience, 2004-2014.

Cairns R, Daniels B, Wood DA, Brett J.

Med J Aust. 2016 Mar 7;204(4):154.

PMID:
26937669
46.

Misuse and Associated Harms of Quetiapine and Other Atypical Antipsychotics.

Montebello ME, Brett J.

Curr Top Behav Neurosci. 2017;34:125-139. doi: 10.1007/7854_2015_424.

PMID:
26695164
47.

Management of benzodiazepine misuse and dependence.

Brett J, Murnion B.

Aust Prescr. 2015 Oct;38(5):152-5. Epub 2015 Oct 1. Review.

48.

Concerns about quetiapine.

Brett J.

Aust Prescr. 2015 Jun;38(3):95-7. Epub 2015 Jun 1. Review.

49.
50.

Mind the gap: What is the difference between alcohol treatment need and access for Aboriginal and Torres Strait Islander Australians?

Brett J, Lee KS, Gray D, Wilson S, Freeburn B, Harrison K, Conigrave K.

Drug Alcohol Rev. 2016 Jul;35(4):456-60. doi: 10.1111/dar.12313. Epub 2015 Aug 31.

PMID:
26331675

Supplemental Content

Support Center